Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5278]

Cancer-killing combination therapies unveiled with new drug-screening tool

Cancer-killing combination therapies unveiled with new drug-screening tool

Researchers identify one way T cell function may fail in cancer

Researchers identify one way T cell function may fail in cancer

FDA approves palbociclib for male patients with HR-positive/HER2-negative breast cancer

FDA approves palbociclib for male patients with HR-positive/HER2-negative breast cancer

New hope for treating childhood brain cancer

New hope for treating childhood brain cancer

Using a promiscuous inhibitor to uncover cancer drug targets

Using a promiscuous inhibitor to uncover cancer drug targets

Blocking epigenetic Swiss army knife may be a new strategy for treating colorectal cancer

Blocking epigenetic Swiss army knife may be a new strategy for treating colorectal cancer

AACR 2019: LOXO-195 promising against tumours with acquired resistance to first-generation therapeutics

AACR 2019: LOXO-195 promising against tumours with acquired resistance to first-generation therapeutics

AACR 2019: Adavosertib speeds cancer cells into the wall of mitotic catastrophe

AACR 2019: Adavosertib speeds cancer cells into the wall of mitotic catastrophe

AACR 2019: Gilteritinib improved survival for patients with acute myeloid leukaemia

AACR 2019: Gilteritinib improved survival for patients with acute myeloid leukaemia

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab is safe

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab...

More from ecancer